These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9395317)

  • 21. Lipid-peptide association and activation of lecithin:cholesterol acyltransferase. Effect of alpha-helicity.
    Ponsin G; Hester L; Gotto AM; Pownall HJ; Sparrow JT
    J Biol Chem; 1986 Jul; 261(20):9202-5. PubMed ID: 3722196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lecithin cholesterol acyltransferase (LCAT) activity in the presence of Apo-AI-derived peptides exposed to disorder-order conformational transitions.
    Aguilar-Espinosa SL; Mendoza-Espinosa P; Delgado-Coello B; Mas-Oliva J
    Biochem Biophys Res Commun; 2013 Nov; 441(2):469-75. PubMed ID: 24383078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of the surface lipid composition of reconstituted LPA-I on apolipoprotein A-I structure and lecithin: cholesterol acyltransferase activity.
    Sparks DL; Frank PG; Neville TA
    Biochim Biophys Acta; 1998 Feb; 1390(2):160-72. PubMed ID: 9507105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Composition and structural and functional properties of discoidal and spherical phospholipid-apoE3 complexes.
    De Pauw M; Vanloo B; Dergunov AD; Devreese AM; Baert J; Brasseur R; Rosseneu M
    Biochemistry (Mosc); 1997 Mar; 62(3):251-63. PubMed ID: 9275298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deletion of specific glycan chains affects differentially the stability, local structures, and activity of lecithin-cholesterol acyltransferase.
    Kosman J; Jonas A
    J Biol Chem; 2001 Oct; 276(40):37230-6. PubMed ID: 11486003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural and functional properties of two mutants of lecithin-cholesterol acyltransferase (T123I and N228K).
    Adimoolam S; Jin L; Grabbe E; Shieh JJ; Jonas A
    J Biol Chem; 1998 Dec; 273(49):32561-7. PubMed ID: 9829992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanistic Insights into the Activation of Lecithin-Cholesterol Acyltransferase in Therapeutic Nanodiscs Composed of Apolipoprotein A-I Mimetic Peptides and Phospholipids.
    Giorgi L; Niemelä A; Kumpula EP; Natri O; Parkkila P; Huiskonen JT; Koivuniemi A
    Mol Pharm; 2022 Nov; 19(11):4135-4148. PubMed ID: 36111986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of functional residues in the interfacial recognition domain of lecithin cholesterol acyltransferase (LCAT).
    Peelman F; Vanloo B; Perez-Mendez O; Decout A; Verschelde JL; Labeur C; Vinaimont N; Verhee A; Duverger N; Brasseur R; Vandekerckhove J; Tavernier J; Rosseneu M
    Protein Eng; 1999 Jan; 12(1):71-8. PubMed ID: 10065713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between structure and biochemical phenotype of lecithin:cholesterol acyltransferase (LCAT) mutants causing fish-eye disease.
    Vanloo B; Peelman F; Deschuymere K; Taveirne J; Verhee A; Gouyette C; Labeur C; Vandekerckhove J; Tavernier J; Rosseneu M
    J Lipid Res; 2000 May; 41(5):752-61. PubMed ID: 10787436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deletion of N-terminal amino acids from human lecithin:cholesterol acyltransferase differentially affects enzyme activity toward alpha- and beta-substrate lipoproteins.
    Vickaryous NK; Teh EM; Stewart B; Dolphin PJ; Too CK; McLeod RS
    Biochim Biophys Acta; 2003 Mar; 1646(1-2):164-72. PubMed ID: 12637024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies of synthetic peptides of human apolipoprotein A-I containing tandem amphipathic alpha-helixes.
    Mishra VK; Palgunachari MN; Datta G; Phillips MC; Lund-Katz S; Adeyeye SO; Segrest JP; Anantharamaiah GM
    Biochemistry; 1998 Jul; 37(28):10313-24. PubMed ID: 9665740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LCAT activation properties of apo A-I CNBr fragments and conversion of discoidal complexes into spherical particles.
    Vanloo B; Taveirne J; Baert J; Lorent G; Lins L; Ruyschaert JM; Rosseneu M
    Biochim Biophys Acta; 1992 Oct; 1128(2-3):258-66. PubMed ID: 1420299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of end group blockage on the properties of a class A amphipathic helical peptide.
    Venkatachalapathi YV; Phillips MC; Epand RM; Epand RF; Tytler EM; Segrest JP; Anantharamaiah GM
    Proteins; 1993 Apr; 15(4):349-59. PubMed ID: 8460106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lecithin cholesterol acyltransferase.
    Jonas A
    Biochim Biophys Acta; 2000 Dec; 1529(1-3):245-56. PubMed ID: 11111093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conformation and lipid binding of a C-terminal (198-243) peptide of human apolipoprotein A-I.
    Zhu HL; Atkinson D
    Biochemistry; 2007 Feb; 46(6):1624-34. PubMed ID: 17279626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lecithin:cholesterol acyltransferase activation and lipid binding by synthetic fragments of apolipoprotein C-I.
    Soutar AK; Sigler GF; Smith LC; Gotto AM; Sparrow JT
    Scand J Clin Lab Invest Suppl; 1978; 150():53-8. PubMed ID: 746357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electrostatic and hydrophobic forces tether the proximal region of the angiotensin II receptor (AT1A) carboxyl terminus to anionic lipids.
    Mozsolits H; Unabia S; Ahmad A; Morton CJ; Thomas WG; Aguilar MI
    Biochemistry; 2002 Jun; 41(24):7830-40. PubMed ID: 12056915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of lecithin:cholesterol acyltransferase with lipid surfaces and apolipoprotein A-I-derived peptides.
    Casteleijn MG; Parkkila P; Viitala T; Koivuniemi A
    J Lipid Res; 2018 Apr; 59(4):670-683. PubMed ID: 29438987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of N-linked glycosylation of lecithin:cholesterol acyltransferase in lipoprotein substrate specificity.
    O K; Hill JS; Pritchard PH
    Biochim Biophys Acta; 1995 Jan; 1254(2):193-7. PubMed ID: 7827124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of increasing hydrophobicity on the physical-chemical and biological properties of a class A amphipathic helical peptide.
    Datta G; Chaddha M; Hama S; Navab M; Fogelman AM; Garber DW; Mishra VK; Epand RM; Epand RF; Lund-Katz S; Phillips MC; Segrest JP; Anantharamaiah GM
    J Lipid Res; 2001 Jul; 42(7):1096-104. PubMed ID: 11441137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.